Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 3c, Revenues Beat; Maintains FY20 EPS/Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 19.95 -0.26 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.21 | 52 Week High | $0.19 | |||
| Open | $20.55 | 52 Week Low | $0.07 | |||
| Day High | $20.55 | P/E | N/A | |||
| Day Low | $19.02 | EPS | $-0.01 | |||
| Volume | 7,234,748 | |||||
